These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12672518)

  • 21. Treatment in resectable non-metastatic adenocarcinoma of stomach: Changing paradigms.
    Chelakkot PG; Ravind R; Sruthi K; Menon D
    Indian J Cancer; 2019; 56(1):74-80. PubMed ID: 30950450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
    Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M
    Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].
    Shah MA; Kelsen DP
    Chirurg; 2002 Apr; 73(4):325-30. PubMed ID: 12063916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer.
    Yoshikawa T; Morita S; Tanabe K; Nishikawa K; Ito Y; Matsui T; Fujitani K; Kimura Y; Fujita J; Aoyama T; Hayashi T; Cho H; Tsuburaya A; Miyashita Y; Sakamoto J
    Eur J Cancer; 2016 Jul; 62():103-11. PubMed ID: 27244537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal therapy of gastric cancer.
    Mlkvý P
    Dig Dis; 2010; 28(4-5):615-8. PubMed ID: 21088412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant therapy in gastric cancer.
    Lim L; Michael M; Mann GB; Leong T
    J Clin Oncol; 2005 Sep; 23(25):6220-32. PubMed ID: 16135489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving Outcomes in Resectable Gastric Cancer: A Review of Current and Future Strategies.
    Chan BA; Jang RW; Wong RK; Swallow CJ; Darling GE; Elimova E
    Oncology (Williston Park); 2016 Jul; 30(7):635-45. PubMed ID: 27422110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and future directions in the treatment of localized gastric cancer.
    Wils J; Meyer HJ; Wilke H
    Ann Oncol; 1994; 5 Suppl 3():69-72. PubMed ID: 8204532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline.
    Earle CC; Maroun J; Zuraw L;
    Can J Surg; 2002 Dec; 45(6):438-46. PubMed ID: 12500920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.
    Kim JP; Kwon OJ; Oh ST; Yang HK
    Ann Surg; 1992 Sep; 216(3):269-78; discussion 278-9. PubMed ID: 1417176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the treatment of gastric cancer.
    Sun W; Haller DG
    Drugs; 2001; 61(11):1545-51. PubMed ID: 11577792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multidisciplinary treatment for gastric cancer with peritoneal metastasis].
    Ishigami H; Kitayama J; Yamaguchi H; Emoto S; Watanabe T
    Gan To Kagaku Ryoho; 2012 Dec; 39(13):2460-3. PubMed ID: 23235165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy in gastric and cardia cancer: should we irradiate?
    Van Laethem JL; Demols A
    Curr Opin Oncol; 2006 Jul; 18(4):381-5. PubMed ID: 16721135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study.
    Newman E; Potmesil M; Ryan T; Marcus S; Hiotis S; Yee H; Norwood B; Wendell M; Muggia F; Hochster H
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S97-100. PubMed ID: 16399443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric cancer treatment: a systematic review.
    Berardi R; Scartozzi M; Romagnoli E; Antognoli S; Cascinu S
    Oncol Rep; 2004 Apr; 11(4):911-6. PubMed ID: 15010894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Management of Gastric Cancer in Europe.
    Gramaticu IM; Croitoru AE
    Chirurgia (Bucur); 2018; 113(6):758-764. PubMed ID: 30596363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.